The HSP immune network in cancer
Z Albakova, Y Mangasarova - Frontiers in immunology, 2021 - frontiersin.org
Heat shock proteins are molecular chaperones which support tumor development by
regulating various cellular processes including unfolded protein response, mitochondrial …
regulating various cellular processes including unfolded protein response, mitochondrial …
HSP70s in breast cancer: promoters of tumorigenesis and potential targets/tools for therapy
AE Kabakov, VL Gabai - Cells, 2021 - mdpi.com
The high frequency of breast cancer worldwide and the high mortality among women with
this malignancy are a serious challenge for modern medicine. A deeper understanding of …
this malignancy are a serious challenge for modern medicine. A deeper understanding of …
USP2 promotes tumor immune evasion via deubiquitination and stabilization of PD-L1
Z Kuang, X Liu, N Zhang, J Dong, C Sun… - Cell Death & …, 2023 - nature.com
The abnormal upregulation of programmed death ligand-1 (PD-L1) on tumor cells impedes
T-cell mediated cytotoxicity through PD-1 engagement, and further exploring the …
T-cell mediated cytotoxicity through PD-1 engagement, and further exploring the …
[HTML][HTML] Inhibition of Galectin-9 sensitizes tumors to anthracycline treatment via inducing antitumor immunity
Anthracyclines are a class of conventionally and routinely used first-line chemotherapy
drugs for cancer treatment. In addition to the direct cytotoxic effects, increasing evidence …
drugs for cancer treatment. In addition to the direct cytotoxic effects, increasing evidence …
Tubulin isotypes: emerging roles in defining cancer stem cell niche
TT Maliekal, D Dharmapal, S Sengupta - Frontiers in Immunology, 2022 - frontiersin.org
Although the role of microtubule dynamics in cancer progression is well-established, the
roles of tubulin isotypes, their cargos and their specific function in the induction and …
roles of tubulin isotypes, their cargos and their specific function in the induction and …
Long Noncoding RNA Hotair Promotes the Progression and Immune Escape in Laryngeal Squamous Cell Carcinoma through MicroRNA‐30a/GRP78/PD‐L1 Axis
X Yuan, Q Shen, W Ma - Journal of Immunology Research, 2022 - Wiley Online Library
Homeobox (HOX) transcript antisense RNA (Hotair) is elevated in many cancers
significantly. However, the oncogenic role of Hotair in human laryngeal squamous cell …
significantly. However, the oncogenic role of Hotair in human laryngeal squamous cell …
Prolyl isomerase Pin1 sculpts the immune microenvironment of colorectal cancer
Y Li, Z Yuan, L Wang, J Yang, P Pu, Y Le, XW Chen… - Cellular …, 2024 - Elsevier
Pin1, a peptide prolyl cis-trans isomerase, is overexpressed and/or overactivated in many
human malignancies. However, whether Pin1 regulates the immunosuppressive TME has …
human malignancies. However, whether Pin1 regulates the immunosuppressive TME has …
GRP78 as a potential therapeutic target in cancer treatment: an updated review of its role in chemoradiotherapy resistance of cancer cells
M Lin, Y Mo, C Li, Y Liu, X Feng - Medical Oncology, 2025 - Springer
Abstract GRP78 (Glucose-related protein 78, BiP/HSPA5) is commonly overexpressed in
cancer cells. Acting as an activator of endoplasmic reticulum stress, GRP78 is involved in …
cancer cells. Acting as an activator of endoplasmic reticulum stress, GRP78 is involved in …
Thymoquinone, a Novel Multi-Strike Inhibitor of Pro-Tumorigenic Breast Cancer (BC) Markers: CALR, NLRP3 Pathway and sPD-L1 in PBMCs of HR+ and TNBC …
S Elgohary, RA Eissa, HM El Tayebi - International Journal of Molecular …, 2023 - mdpi.com
Breast cancer (BC) is not only a mass of malignant cells but also a systemic inflammatory
disease. BC pro-tumorigenic inflammation has been shown to promote immune evasion and …
disease. BC pro-tumorigenic inflammation has been shown to promote immune evasion and …
[HTML][HTML] THADA drives Golgi residency and upregulation of PD-L1 in cancer cells and provides promising target for immunotherapy
C Li, H Chi, S Deng, K Xu, H Wang, H Yao… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background The abnormal upregulation of programmed death-ligand 1 (PD-L1) in cancer
cells inhibits T cell-mediated cytotoxicity, but the molecular mechanisms that drive and …
cells inhibits T cell-mediated cytotoxicity, but the molecular mechanisms that drive and …